BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 3624507)

  • 1. Prospective study of scheduled withdrawal from nortriptyline in children and adolescents.
    Geller B; Cooper TB; Carr LG; Warham JE; Rodriguez A
    J Clin Psychopharmacol; 1987 Aug; 7(4):252-4. PubMed ID: 3624507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychosis after discontinuation of nortriptyline.
    Patterson JF
    J Clin Psychopharmacol; 1984 Apr; 4(2):117-8. PubMed ID: 6707238
    [No Abstract]   [Full Text] [Related]  

  • 3. A retrospective study of serum levels and electrocardiographic effects of nortriptyline in children and adolescents.
    Wilens TE; Biederman J; Spencer T; Geist DE
    J Am Acad Child Adolesc Psychiatry; 1993 Mar; 32(2):270-7. PubMed ID: 8444754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Child and adolescent nortriptyline single dose kinetics predict steady state plasma levels and suggested dose: preliminary data.
    Geller B; Cooper TB; Chestnut EC; Anker JA; Price DT; Yates E
    J Clin Psychopharmacol; 1985 Jun; 5(3):154-8. PubMed ID: 3998205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Withdrawal symptoms in critically ill children after long-term administration of sedatives and/or analgesics: a first evaluation.
    Ista E; van Dijk M; Gamel C; Tibboel D; de Hoog M
    Crit Care Med; 2008 Aug; 36(8):2427-32. PubMed ID: 18596622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term amitriptyline in chronic depression.
    Giller E; Bialos D; Harkness L; Jatlow P; Waldo M
    Hillside J Clin Psychiatry; 1985; 7(1):16-33. PubMed ID: 3894196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serial monitoring and achievement of steady state nortriptyline plasma levels in depressed children and adolescents: preliminary data.
    Geller B; Cooper TB; Chestnut EC
    J Clin Psychopharmacol; 1985 Aug; 5(4):213-6. PubMed ID: 4019809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nortriptyline pharmacokinetic parameters in depressed children and adolescents: preliminary data.
    Geller B; Cooper TB; Chestnut E; Abel AS; Anker JA
    J Clin Psychopharmacol; 1984 Oct; 4(5):265-9. PubMed ID: 6490962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial of nortriptyline combined with transdermal nicotine for smoking cessation.
    Prochazka AV; Kick S; Steinbrunn C; Miyoshi T; Fryer GE
    Arch Intern Med; 2004 Nov; 164(20):2229-33. PubMed ID: 15534159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nortriptyline and EEG sleep in depressed patients.
    Kupfer DJ; Spiker DG; Rossi A; Coble PA; Shaw D; Ulrich R
    Biol Psychiatry; 1982 May; 17(5):535-46. PubMed ID: 7093390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nortriptyline in the hospitalized elderly: tolerance and side effect reduction.
    Rosen J; Sweet R; Pollock BG; Mulsant BH
    Psychopharmacol Bull; 1993; 29(2):327-31. PubMed ID: 8290682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eighteen months of drug treatment for depression: predicting relapse and recovery.
    Mulder RT; Frampton CM; Luty SE; Joyce PR
    J Affect Disord; 2009 Apr; 114(1-3):263-70. PubMed ID: 18805590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of yohimbine to counteract nortriptyline-induced orthostatic hypotension.
    Seibyl JP; Krystal JH; Price LH; Charney DS
    J Clin Psychopharmacol; 1989 Feb; 9(1):67-8. PubMed ID: 2708559
    [No Abstract]   [Full Text] [Related]  

  • 14. High initial nortriptyline doses in the treatment of depression.
    Warner MD; Griffin M; Peabody CA
    J Clin Psychiatry; 1993 Feb; 54(2):67-9. PubMed ID: 8444823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective study of lithium augmentation in antidepressant-resistant geriatric depression.
    Flint AJ; Rifat SL
    J Clin Psychopharmacol; 1994 Oct; 14(5):353-6. PubMed ID: 7806693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretreatment systolic orthostatic blood pressure and treatment response in geriatric depression: a revisit.
    Diehl DJ; Houck PR; Paradis C; Miller M; Reynolds CF
    J Clin Psychopharmacol; 1993 Jun; 13(3):189-93. PubMed ID: 8354735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tranylcypromine withdrawal phenomena.
    Halle MT; Dilsaver SC
    J Psychiatry Neurosci; 1993 Jan; 18(1):49-50. PubMed ID: 8461282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nortriptyline capacity-limited metabolism: a case report.
    Browne JL; Perry PJ; Taylor JW; Sieleni BA; Kronfol Z
    J Clin Psychopharmacol; 1984 Dec; 4(6):322-5. PubMed ID: 6511999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A common P-glycoprotein polymorphism is associated with nortriptyline-induced postural hypotension in patients treated for major depression.
    Roberts RL; Joyce PR; Mulder RT; Begg EJ; Kennedy MA
    Pharmacogenomics J; 2002; 2(3):191-6. PubMed ID: 12082591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid detoxification from opioid dependence under general anaesthesia versus standard methadone tapering: abstinence rates and withdrawal distress experiences.
    Krabbe PF; Koning JP; Heinen N; Laheij RJ; van Cauter RM; De Jong CA
    Addict Biol; 2003 Sep; 8(3):351-8. PubMed ID: 13129838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.